JODI CROUSE: Open Payments
NPI 1770003428 · ELMIRA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 27 payments from 9 companies in 2025. Trend: 2023 $653 · 2024 $865 · 2025 $406
Food & beverage: $396Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $162 |
| UCB, Inc. | 4 | $85 |
| GENZYME CORPORATION | 1 | $33 |
| Organon LLC | 3 | $24 |
| Janssen Biotech, Inc. | 1 | $24 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $22 |
| Biofrontera Inc. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: SKYRIZI, Bimzelx, DUPIXENT, VTAMA, TREMFYA, ILUMYA, BF-RHODOLED, COSENTYX.
Industry payments across NY — which companies pay providers there.
